Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund I Fonds VALOR 120191237 / ISIN LU2488120796

So investiert der Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund I Fonds: To increase the value of its shares, over the long term, through growth in the value of, and income from, its investments. The fund is actively managed and invests mainly in a diversified portfolio of shares of companies that are involved in the research, development, production, or distribution of products or services related to health sciences. The companies may be anywhere in the world, including emerging markets, with a focus on companies in the United States.